Circulating levels of ATP is a biomarker of HIV cognitive impairment

Stephani Velasquez, Lisa Prevedel, Silvana Valdebenito, Anna Górska, Mikhail Y. Golovko, Nabab Khan, Jonathan D. Geiger, Eliseo A. Eugenín

EBioMedicine · 2019 · 49 citations · 71 references

DOIFull text

Open access

Concepts

Abstract

BACKGROUND: In developed countries, Human Immunodeficiency Virus type-1 (HIV-1) infection has become a chronic disease despite the positive effects of anti-retroviral therapies (ART), but still at least half of the HIV infected population shown signs of cognitive impairment. Therefore, biomarkers of HIV cognitive decline are urgently needed. METHODS: and ATP as well as cogntive status of the individuals analyzed. FINDINGS: and ATP were detected. Circulating levels of ATP were correlated with cognitive decline in the HIV-infected population supporting that ATP is a biomarker of cognitive disease in the HIV-infected population. INTERPRETATION: We propose that circulating levels of ATP could predict CNS compromise and lead to the breakthroughs necessary to detect and prevent brain compromise in the HIV-infected population.

References

71